These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24717950)

  • 1. Nasal peak inspiratory and expiratory flow measurements for assessing nasal obstruction in allergic rhinitis.
    Kirtsreesakul V; Leelapong J; Ruttanaphol S
    Am J Rhinol Allergy; 2014; 28(2):126-30. PubMed ID: 24717950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of IgE-mediated hypersensitivity on nasal mucociliary clearance.
    Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):801-6. PubMed ID: 20713757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pretreatment nasal symptoms on treatment outcome in allergic rhinitis.
    Kirtsreesakul V; Chansaksung P; Ruttanaphol S
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):376-81. PubMed ID: 20172384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between nasal symptom and mucociliary clearance in allergic rhinitis.
    Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S
    Laryngoscope; 2009 Aug; 119(8):1458-62. PubMed ID: 19507239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between Peak Nasal Flow Reversibility and Mucociliary Clearance in Allergic Rhinitis.
    Kirtsreesakul V; Leelapong J; Ruttanaphol S
    Laryngoscope; 2020 Jun; 130(6):1372-1376. PubMed ID: 31385622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of nasal steroids on nonallergic rhinitis and the associated inflammatory cell phenotypes.
    Kirtsreesakul V; Hararuk K; Leelapong J; Ruttanaphol S
    Am J Rhinol Allergy; 2015; 29(5):343-9. PubMed ID: 26358345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of once daily triamcinolone acetonide aqueous nasal spray in adults with non-allergic and allergic rhinitis.
    Baccioglu Kavut A; Kalpaklıoğlu F
    Allergol Immunopathol (Madr); 2013; 41(6):374-80. PubMed ID: 23031657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of peak nasal inspiratory flow, peak oral inspiratory flow, and the nasal patency index.
    Tsounis M; Swart KM; Georgalas C; Markou K; Menger DJ
    Laryngoscope; 2014 Dec; 124(12):2665-9. PubMed ID: 25073629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?
    Koo Ng NK; Young D; McGarry GW
    J Laryngol Otol; 2012 Dec; 126(12):1238-40. PubMed ID: 23057871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related effect of intranasal corticosteroids on treatment outcome of persistent allergic rhinitis.
    Kirtsreesakul V; Chansaksung P; Ruttanaphol S
    Otolaryngol Head Neck Surg; 2008 Oct; 139(4):565-9. PubMed ID: 18922345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment.
    Oztürk F; Türktaş I; Asal K; Ileri F; Münevver Pinar N
    Int J Pediatr Otorhinolaryngol; 2004 Aug; 68(8):1007-15. PubMed ID: 15236886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term repeatability and correlates of laboratory measures of nasal function in patients with seasonal allergic rhinitis.
    Sims EJ; Wilson AM; White PS; Gardiner Q; Lipworth BJ
    Rhinology; 2002 Jun; 40(2):66-8. PubMed ID: 12091995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peak flow nasal patency indices in patients operated for nasal obstruction.
    Larsen K; Oxhøj H; Grøntved A; Kristensen S
    Eur Arch Otorhinolaryngol; 1990; 248(1):21-4. PubMed ID: 2083069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal budesonide in children affected by persistent allergic rhinitis and its effect on nasal patency and Nasal Obstruction Symptom Evaluation (NOSE) score.
    Zicari AM; Occasi F; Montanari G; Indinnimeo L; De Castro G; Tancredi G; Duse M
    Curr Med Res Opin; 2015 Mar; 31(3):391-6. PubMed ID: 25629793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nasal peak flow to assess nasal patency.
    Phagoo SB; Watson RA; Pride NB
    Allergy; 1997 Sep; 52(9):901-8. PubMed ID: 9298174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinomanometry and nasal peak expiratory and inspiratory flow rate.
    Wihl JA; Malm L
    Ann Allergy; 1988 Jul; 61(1):50-5. PubMed ID: 3389572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis.
    Klossek JM; Laliberté F; Laliberté MF; Mounedji N; Bousquet J
    Rhinology; 2001 Mar; 39(1):17-22. PubMed ID: 11340690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a Pretreatment Visual Analog Scale Predict Treatment Outcome in Allergic Rhinitis?
    Kirtsreesakul V; Leelapong J; Ruttanaphol S
    Int Arch Allergy Immunol; 2020; 181(4):285-291. PubMed ID: 32018258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between peak nasal inspiratory flow and peak expiratory flow in children and adolescents.
    Chaves C; Ibiapina Cda C; de Andrade CR; Godinho R; Alvim CG; Cruz ÁA
    Rhinology; 2012 Dec; 50(4):381-5. PubMed ID: 23181252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.